Journal Publications

• [1]Zhang TX#, Xiao JN#, Zou YZ*, Yin G*, Natural Killer Cells: A Promising Kit in the Adoptive Cell Therapy Toolbox.Cancers, 2022, 14 (22) : 5657.
• [2]Li YY#, Yin G*, Yan WG*, HOXC10 Promotes Carboplatin Resistance of Ovarian Cancer by Regulating ABCC3.Am J Cancer Res, 2022, 12 (10) : 4602-4621.
• [3]Liu JX#, Yi HX*, Yin G*, Identification of CPT2 as a Prognostic Biomarker by integrating the Metabolism-Associated Gene Signature in Colorectal Cancer.BMC Cancer, 2022, 22 (1) : 1038.
• [4]Liu JQ#, Yin G*, Gil Mor*, Shu G#.TWIST1 induces proteasomal degradation of β-catenin during the differentiation of ovarian cancer stem-like cells.Scientific Reports, 2022, 12 (1) : 15650.
• [5]Yin G*, Sébastien Roger, Shu G, Wu AQ, Li JN, Zhou ZW, Lin Y, Lei H, Fan LL.Hotair promotes the migration and proliferation in ovarian cancer by miR-222-3p/CDK19 axis.Cellular and Molecular Life Sciences, 2022, 79 (5) : 254.
• [6]Yin G*, Shu G*, Niu CX, Zhang XJ, Liu JQ, Wu AQ.Comprehensive Network Analysis of Dysregulated Genes Revealed MNX1-AS1/ hsa-miR-4697-3p/ HOXB13 Axis in OC Chemotherapy Response.Cancer Sci, 2022, 113 (8) : 2627-2641.
• [7]Yin G*, Liu JW*, Xie BT, Gan YQ, Li YM, Lu PY, Deng SM, Liu JX, Shu G, OuYang CL.HDAC5, negatively regulated by miR-148a-3p, promotes colon cancer cell migration.Cancer Sci, 2022, 113 (8) : 2560-2574.
• [8]Zhang TX*, Yin G*, Shu G, Lin Y, Zhou ZW, Gao F.Biology and Clinical Relevance of HCMV-Associated Adaptive NK Cells.Front. Immunol, 2022: 13:830396.
• [9]Yin G*, Shu G, Peng YQ, Peng YL, Lu PY, Li YY, Xiao Q, Liu JQ, Sun RZ, Tian RT, Zhou ZW, Li JN, Liu JX, Gan YQ, Li YM.Downregulation of MEIS1 Mediated by ELFN1-AS1/EZH2/DNMT3a Axis Promotes Tumorigenesis and Oxaliplatin Resistance in Colorectal Cancer.Signal Transduction and Targeted Therapy, 2022, 7 (1) : 87:1343-1355.
• [10]Yin G*, Shu G, Liu JX, Liu JQ, Xiao JN, Xiao Q.Metformin suppresses the growth of colorectal cancer by targeting INHBA to inhibit TGF-β/PI3K/AKT signaling transduction.Cell Death and Disease, 2022, 13 (3) : 202.
• [11]Xiao Q#, Liu JQ#, Yin G*, Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities.Signal Transduction and Targeted Therapy, 2022, 7 (1) : 3:379-401.
• [12]Yin G*, Lin Y, Lei H, Fan LL.Identification of a Gene Set Correlated With Immune Status in Ovarian Cancer by Transcriptome-Wide Data Mining.Frontiers in Molecular Biosciences, 2021: 8:670666.
• [13]Hai RH, Yin G*, Shu G, He LE.Characterization of Histone Deacetylase Mechanisms in Cancer Development.Frontiers in Oncology, 2021: 11:700947.
• [14]Yin G*, Gan YQ, Li YM, Liu JX.Identification of ZNF26 as a prognostic biomarker in colorectal cancer by an integrated bioinformatic analysis.Frontiers in Cell and Developmental Biology, 2021: 9:671211.
• [15]Yin G*, Gan YQ, Xiao Q.MEF2A transcriptionally upregulates the expression of ZEB2 and CTNNB1 in colorectal cancer to promote tumor progression.Oncogene, 2021, 40 (19) : 3364-3377.
• [16]Duan CW*, Yin G*, Xia J, Abudureheman T, Huang WL.CDK9 Inhibitor Induces the Apoptosis of B-Cell Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolytic Metabolism.Frontiers in Cell and Developmental Biology, 2021: 9:641271.
• [17]Yin G*, Lei H, Lin Y, Fan LL.A newly defined risk signature, consisting of three m6A RNA methylation regulators, predicts the prognosis of ovarian cancer.Aging (Albany NY), 2020, 12 (18) : 18453-18475.
• [18]Peng YL, Yin G*, Shu G*, Li YY.HOXC10 promotes tumour metastasis by regulating the EMT-related gene Slug in ovarian cancer.Aging (Albany NY), 2020, 12 (19) : 19375-19398.
• [19]Peng YL, Zhang S, Lei H, Fan LL, Yin G*, Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10.Theranostics, 2020, 10 (13) : 5895-5913.
• [20]Xiao Q, Liu JX, Li YM, Yin G*, Shu G*, EN2 as an oncogene promotes tumor progression via regulating CCL20 in colorectal cancer.Cell Death and Disease, 2020, 11 (7) : 604.